GSK to buy US lung cancer drug specialist Nuvalent for £8bn

GSK to buy US lung cancer drug specialist Nuvalent for £8bn

The Irish News logoThe Irish News

The acquisition is thought to be GSK’s biggest deal in more than a decade.